Pharmanutra launches four new supplements featuring Sucrosomial Technology®

Four new Pharmanutra food supplements will enter the Italian market on 24 September 2026: Apportal^® Master and Apportal^® Junior, designed respectively to support the wellbeing of people over 50 and younger consumers, and Sucrosomial^® Creatine and Pre Start Shot, developed to support athletes’ preparation, performance and recovery. All four products feature Sucrosomial Technology^®, the delivery system conceived and patented by Pharmanutra to promote nutrient absorption and tolerability.

Apportal^® Master and Apportal^® Junior: energy and support for different age groups

Apportal^® Master is designed for people over 50 who want to support physical and mental energy, cognitive function and muscle wellbeing. Each sachet combines 24 nutrients, including Creatine, Vitamin C, Beta-carotene, Royal Jelly, NADH and Zinc, as well as Vitamin D3 and Vitamin B12 in Sucrosomial^® form. The formulation also contains five minerals developed with Sucrosomial Technology^®: Selenium, Iron, Zinc, Magnesium and Iodine. The product is indicated during periods of convalescence, seasonal changes and in cases of physical and mental fatigue.

Apportal^® Junior is formulated to meet the needs of younger people. It contains 19 nutrients, including Vitamin D3, Vitamin B12, Selenium, Iron, Zinc, Magnesium and Royal Jelly. It helps reduce tiredness and fatigue during periods of increased physical and mental stress, convalescence and seasonal changes, while also contributing to the normal function of the immune system with a tonic, energising and restorative action.

With these two new launches, the Apportal^® range now comprises four solutions: Apportal^®, Apportal^® Boost, Apportal^® Master and Apportal^® Junior. Launched in 2018, the range offers complete nutritional supplements to counter tiredness and fatigue and support the normal function of the immune system.

Cetilar^® Nutrition: Sucrosomial^® Creatine and Pre-workout support for athletes

Sucrosomial^® Creatine combines conventional creatine monohydrate and Sucrosomial^® creatine monohydrate in a 50/50 ratio. It was developed for those seeking targeted support during high-intensity activities and looking to improve performance in the most demanding workouts. Applying Sucrosomial Technology^® to creatine for the first time aims to optimise nutrient stability and absorption.

Pre Start Shot is a liquid pre-workout supplement containing amino acids, B vitamins, and Sucrosomial^® Selenium and Chromium. The formula includes Sucrosomial^® Vitamin B12 (UltraB12^®), Sucrosomial^® Selenium (UltraSel^®) and Sucrosomial^® Chromium (Ultrachrome^®), and is designed to prepare the body for exertion, support intense training and help the body manage physical stress.

The two products will be available from 24 September and expand the Cetilar^® Nutrition range, dedicated to targeted supplementation for performance and recovery. All products in the range are Play Sure Doping Free certified, ensuring safety even in competitive sport.

Innovation and research behind Pharmanutra’s new products

Andrea Lacorte, Chairman of Pharmanutra S.p.A., commented: “The launch of these four new products is a source of great pride and enthusiasm for us, as it confirms the extraordinary contribution that Sucrosomial® Technology can make to the development of new solutions. It enables us to create highly scientific formulations that are truly specific to individual target groups, while maintaining the highest levels of nutrient absorption and tolerability, with a unique and distinctive synergistic effect among the various components. Our ongoing focus is to apply the uniqueness of our technology to different nutrients, always placing science first. This increasingly makes us a reference point and a valuable partner for the medical and scientific community. Sucrosomial® Creatine deserves a special mention because, for the first time, we have combined our technology with creatine, with a level of scientific rigour and quality of which we are very proud. We believe the product will be truly revolutionary in its segment, also because it was developed through dialogue with our partners and sports professionals who, being accustomed to high-performance contexts, have helped identify what can genuinely be useful during moments of high-intensity physical exertion. Pharmanutra is currently in a phase of major development, and the ability to apply our technology across many areas offers highly significant potential for new products, which we will launch both in Italy and in international markets as early as 2027”.